95 related articles for article (PubMed ID: 2513416)
1. Platelet-activating factor stimulates a fos/jun/AP-1 transcriptional signaling system in human neuroblastoma cells.
Squinto SP; Block AL; Braquet P; Bazan NG
J Neurosci Res; 1989 Dec; 24(4):558-66. PubMed ID: 2513416
[TBL] [Abstract][Full Text] [Related]
2. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
[TBL] [Abstract][Full Text] [Related]
4. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.
Jalava A; Mai S
Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020
[TBL] [Abstract][Full Text] [Related]
5. Activation of the human NPY gene during neuroblastoma cell differentiation: induced transcriptional activities of AP-1 and AP-2.
Andersson G; Påhlman S; Parrow V; Johansson I; Hammerling U
Cell Growth Differ; 1994 Jan; 5(1):27-36. PubMed ID: 8123590
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor stimulates transcription of the c-jun proto-oncogene in rat fibroblasts.
Quantin B; Breathnach R
Nature; 1988 Aug; 334(6182):538-9. PubMed ID: 3136398
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor induces phospholipid turnover, calcium flux, arachidonic acid liberation, eicosanoid generation, and oncogene expression in a human B cell line.
Schulam PG; Kuruvilla A; Putcha G; Mangus L; Franklin-Johnson J; Shearer WT
J Immunol; 1991 Mar; 146(5):1642-8. PubMed ID: 1847170
[TBL] [Abstract][Full Text] [Related]
8. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
9. Expression of protooncogenes during lymphocyte activation by growth factors.
Bulanova EG; Budagyan VM; Yarilin AA; Mazurenko NN
Biochemistry (Mosc); 1997 Sep; 62(9):1021-5. PubMed ID: 9457764
[TBL] [Abstract][Full Text] [Related]
10. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
11. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
12. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
13. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
Whisler RL; Chen M; Beiqing L; Carle KW
Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
[TBL] [Abstract][Full Text] [Related]
14. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
15. Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha.
Brenner DA; O'Hara M; Angel P; Chojkier M; Karin M
Nature; 1989 Feb; 337(6208):661-3. PubMed ID: 2537468
[TBL] [Abstract][Full Text] [Related]
16. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
17. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor is a messenger in the electroconvulsive shock-induced transcriptional activation of c-fos and zif-268 in hippocampus.
Marcheselli VL; Bazan NG
J Neurosci Res; 1994 Jan; 37(1):54-61. PubMed ID: 8145303
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
Tay DL; Hoffbrand AV; Wickremasinghe GR
Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
[TBL] [Abstract][Full Text] [Related]
20. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
Deng T; Karin M
Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
